CLS Holdings USA, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Document And Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Accounting Policies, by Policy (Policies)
Notes Tables
Notes Details

Accounts Receivable

Accounts Receivable	9 Months Ended
Feb. 29, 2024
Receivables [Abstract]
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	Note 4: Accounts Receivable Accounts receivable was $954,020 and $431,204 at February 29, 2024 and May 31, 2023, respectively. The Company had bad debt expense of $0 and $438 during the three months ended February 29, 2024 and February 28, 2023. The Company had bad debt expense of $393 and $(4,437) during the nine months ended February 29, 2024 and February 28, 2023. No allowance for doubtful accounts was necessary during the three months ended February 29, 2024 and February 28, 2023.

Accounts Receivable

9 Months Ended

Feb. 29, 2024

Receivables [Abstract]

Loans, Notes, Trade and Other Receivables Disclosure [Text Block]

Note 4: Accounts Receivable

Accounts receivable was $954,020 and $431,204 at February 29, 2024 and May 31, 2023, respectively. The Company had bad debt expense of $0 and $438 during the three months ended February 29, 2024 and February 28, 2023. The Company had bad debt expense of $393 and $(4,437) during the nine months ended February 29, 2024 and February 28, 2023. No allowance for doubtful accounts was necessary during the three months ended February 29, 2024 and February 28, 2023.